Csl Ltd has released a press release.
Full Year Results Announcement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CSL
- Full Year Statutory Accounts
- CSL Lifts Profit Guidance
- CEOs AGM Presentation
- New Debt Facilities
- FDA Approves Privigen for CIDP Indication
Later from CSL
- CSL R&D Investor Briefing
- Appendix 4D and Half Year Accounts
- Half Year Results Analyst Presentation
- Update on CSL transition to own distributor model in china
- CSL Full Year Statutory Accounts for the Year Ended 30/06/19
Follow CSL into a list and get an email when it puts out news.
Follow CSL